PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,206,000 | +28.8% | 103,700 | +2.8% | 0.82% | +36.6% |
| Q2 2022 | $4,042,000 | +44.5% | 100,900 | +34.5% | 0.60% | +76.7% |
| Q1 2022 | $2,798,000 | -6.3% | 75,000 | 0.0% | 0.34% | +11.9% |
| Q4 2021 | $2,987,000 | +7.0% | 75,000 | 0.0% | 0.30% | -0.3% |
| Q3 2021 | $2,791,000 | -12.0% | 75,000 | 0.0% | 0.30% | -13.9% |
| Q2 2021 | $3,170,000 | -10.7% | 75,000 | 0.0% | 0.35% | -18.5% |
| Q1 2021 | $3,551,000 | -27.3% | 75,000 | -6.2% | 0.43% | -40.4% |
| Q4 2020 | $4,882,000 | +74.0% | 80,000 | +33.3% | 0.73% | +36.2% |
| Q3 2020 | $2,805,000 | +10.6% | 60,000 | +20.0% | 0.53% | +1.3% |
| Q2 2020 | $2,537,000 | +13.7% | 50,000 | 0.0% | 0.53% | -11.1% |
| Q1 2020 | $2,231,000 | -7.1% | 50,000 | 0.0% | 0.59% | +23.6% |
| Q4 2019 | $2,402,000 | +255.3% | 50,000 | +150.0% | 0.48% | +221.5% |
| Q3 2019 | $676,000 | -24.9% | 20,000 | 0.0% | 0.15% | -21.2% |
| Q2 2019 | $900,000 | – | 20,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |